Bhai log, ek zabardast news hai! World Health Organization (WHO) ne apne ek bade initiative ke liye India ke Translational Health Science and Technology Institute (THSTI) ko regional biomanufacturing training center banaya hai. Socho, So...
Read More
Arre yaar, Lupin ne Q4FY26 aur poore saal ke liye ekdum tagde results diye hain, revenue aur profit dono badha hai. Par sabse funny baat ye hai ki itne acche numbers aane ke baad bhi stock neeche gir gaya. Investors soch rahe hain, 'Ye k...
Read More
Biocon investors ke liye khabar achi nahi hai. Q4 FY26 mein company ka profit seedha **56.8%** gir gaya hai, yani ₹198.6 crore ho gaya hai, jo pichle saal **₹459.4 crore** tha. Yeh sab badhti costs aur kuch exceptional items ki wajah se...
Read More
Yaar, Biocon ke investors ke liye aaj mixed khabar hai. Company ka Q4 FY26 mein net profit **63.5%** gir kar **₹126 crore** ho gaya, jo pichhle saal ke muqable kaafi kam hai. Lekin iske peeche kuch reasons hain aur company ka main busine...
Read More
Bro, Torrent Pharma ne India ke naye generic semaglutide market mein pehle hi mahine mein sabko peeche chhod diya hai. Unhone seedha **38%** market share pakad liya aur April mein **₹17 Crore** ki sales ki hai. Unka dual launch strategy,...
Read More
Bhai log, Lupin ne FY26 ka Q4 ekdum dhamakedaar closing kiya hai! Net profit mein **89%** ka zabardast jump aaya hai, jo ab **₹1,460 Crore** ho gaya hai. Revenue bhi **31.9%** badh kar **₹7,475 Crore** tak pahunch gaya hai, aur company n...
Read More
Arre suno, Dr. Reddy's Laboratories aur Nestle Health Science ne milkar ek naya product launch kiya hai jiska naam hai Celevida GLP+. Yeh un patients ke liye hai jo India mein GLP-1 ya GIP wali medicines le rahe hain diabetes aur motapa...
Read More
Dr. Reddy's aur Nestlé Health Science ki joint venture ne India mein 'Celevida GLP+' launch kiya hai. Ye special nutritional supplement un patients ke liye hai jo type 2 diabetes aur obesity ke liye GLP-1/GIP therapies le rahe hain. Iska...
Read More
Dekho, ekdum solid deal hui hai! IndiaAI aur ICMR ne milkar public health ko AI power dene ka plan banaya hai. Basically, ek aisa system banega jahaan researchers aur startups ko anonymized medical data milega taaki woh AI use karke new...
Read More
Arre suno suno! Venus Remedies ke liye ek badi khabar hai. Unko Argentina ki regulatory authority se unke antibiotic 'Ceftriaxone' bechne ki approval mil gayi hai. Ye move unke Latin America market mein business badhane ke liye ek dam ma...
Read More
Arre suno! India ka healthcare sector ab bade hospitals se hatkar niche, special areas mein ghus raha hai - jaise fertility, CDMO (drug manufacturing), aur oncology. Investors ko yahan opportunities dikh rahi hain, but companies ko margi...
Read More
Yaar, India ke bade private hospitals ab government health schemes par kam depend karne ka soch rahe hain. Asal mein, paisa milne mein late ho raha hai aur rates bhi kam hain, isliye revenue shayad **3-5%** tak kam ho sakta hai FY27 ke f...
Read More
Arre suno, Sun Pharma ne ek mast win haasil ki hai! Bombay High Court ne United Biotech ko 'Otide' naam istemaal karne se temporarily rok laga diya hai. Court ka kehna hai ki yeh naam Sun Pharma ke 'Octride' se kaafi milta-julta hai aur...
Read More
Arre yaar, ye GLP-1 drugs itne zabardast chal rahe hain ki pharma companies ki toh lottery lag gayi hai, khaas kar Eli Lilly aur Novo Nordisk ki. Lekin is badi success ke chakkar mein pura pharma sector ek 'bubble' risk mein aa gaya hai,...
Read More
Bhai log, suno! Indian companies ne US mein paisa lagane ka record bana diya hai. Total **$20.5 billion** ki pledge di hai. Sabse mazedaar baat yeh hai ki pharma companies ne ismein sabse bada hissa diya hai, lagbhag **$19.1 billion**! Y...
Read More
Bhai log, Zydus Lifesciences ke liye thodi tension wali news hai. Unke Ahmedabad wale Zydus Biologics plant mein USFDA ki GMP inspection hui aur **7** observations mil gayi hain. Company bol rahi hai ki data mein koi issue nahi hai, but...
Read More
Arre bhai, Ajanta Pharma ne Q4 mein sabko surprise kar diya! Company ka net profit **18.4%** jump karke **₹266.7 crore** ho gaya hai, aur US mein generic sales toh **56%** bhag gaye! Zabaradast performance!
Read More
Arre bhaiyo aur behno, Lupin ke liye ekdum solid khabar hai! USFDA ne unke ek rare disease drug ko approve kar diya hai, jiska market potential **$337 million** hai. Aur mazaa toh yeh hai ki company apna Q4 FY26 ka results bhi announce k...
Read More
Arre suno suno! India ke pharma companies ke liye ek badi khabar hai. CDSCO, yani ki desh ka drug regulator, ne ek dam tight rule nikaala hai. Ab se, drug approval ke liye queries ka answer dene ke liye companies ko sirf **30 din** milen...
Read More
Arre bhaiyo, Emcure Pharma ke liye FY27 ekdum zabardast raha hai! Company ka revenue **₹9,204 Crore** tak pahunch gaya, aur profit toh **33%** badh gaya! Ab yeh log aur paisa laga rahe hain expansion aur nayi deals mein.
Read More